Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR

Mutations of components of the mitogen-activated protein kinase pathway, mainly BRAF, are common in serous ovarian borderline tumors, whereas high-grade serous ovarian carcinomas rarely show this feature. With the advent of specific kinase inhibitors active against BRAF-mutated cancers, rapid and se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bösmüller, Hans (VerfasserIn) , Fischer, Anna (VerfasserIn) , Pham, Deborah L. (VerfasserIn) , Fehm, Tanja (VerfasserIn) , Capper, David (VerfasserIn) , Deimling, Andreas von (VerfasserIn) , Bonzheim, Irina (VerfasserIn) , Staebler, Annette (VerfasserIn) , Fend, Falko (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Human pathology
Year: 2012, Jahrgang: 44, Heft: 3, Pages: 329-335
ISSN:1532-8392
DOI:10.1016/j.humpath.2012.07.010
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.humpath.2012.07.010
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0046817712002663
Volltext
Verfasserangaben:Hans Bösmüller, Anna Fischer, Deborah L. Pham, Tanja Fehm, David Capper, Andreas von Deimling, Irina Bonzheim, Annette Staebler, Falko Fend

MARC

LEADER 00000caa a2200000 c 4500
001 1741568218
003 DE-627
005 20220819041006.0
007 cr uuu---uuuuu
008 201201r20132012xx |||||o 00| ||eng c
024 7 |a 10.1016/j.humpath.2012.07.010  |2 doi 
035 |a (DE-627)1741568218 
035 |a (DE-599)KXP1741568218 
035 |a (OCoLC)1341382880 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bösmüller, Hans  |e VerfasserIn  |0 (DE-588)1135598339  |0 (DE-627)890514178  |0 (DE-576)489862896  |4 aut 
245 1 0 |a Detection of the BRAF V600E mutation in serous ovarian tumors  |b a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR  |c Hans Bösmüller, Anna Fischer, Deborah L. Pham, Tanja Fehm, David Capper, Andreas von Deimling, Irina Bonzheim, Annette Staebler, Falko Fend 
264 1 |c 2013 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 22 October 2012 
500 |a Gesehen am 01.12.2020 
520 |a Mutations of components of the mitogen-activated protein kinase pathway, mainly BRAF, are common in serous ovarian borderline tumors, whereas high-grade serous ovarian carcinomas rarely show this feature. With the advent of specific kinase inhibitors active against BRAF-mutated cancers, rapid and sensitive detection of the BRAF V600E, by far the most common mutation of this gene, is of great practical relevance. Currently, BRAF mutations are detected by DNA-based techniques. Recently, a monoclonal antibody (VE1) specific for the BRAF V600E protein suitable for archival tissues has been described. In this study, we compared detection of the V600E mutation in serous ovarian tumors by VE1 immunostaining and by allele-specific polymerase chain reaction. All 141 cases of high-grade serous ovarian cancer showed negative or rarely weak, diffuse background VE1 immunostaining, and BRAF wild type was confirmed by molecular analysis in all tested cases. In contrast, 1 (14%) of 7 low-grade serous carcinomas and 22 (71%) of 31 serous borderline tumors revealed moderate to strong VE1 positivity. Immunostaining was clearly evaluable in all cases with sufficient tumor cells, and only rare cases with narrow cytoplasm were difficult to interpret. The V600E mutation was confirmed by allele-specific polymerase chain reaction and sequencing in all VE1-positive cases. Two VE1-positive cases with low epithelial cell content required repeat microdissection to confirm the presence of the mutation. Immunohistochemistry with the VE1 antibody is a specific and sensitive tool for detection of the BRAF V600E mutation in serous ovarian tumors and may provide a practical screening test, especially in tumor samples with low epithelial content. 
534 |c 2012 
650 4 |a Allele-specific PCR 
650 4 |a Immunohistochemistry 
650 4 |a mutation 
650 4 |a Serous ovarian tumors 
700 1 |a Fischer, Anna  |e VerfasserIn  |4 aut 
700 1 |a Pham, Deborah L.  |e VerfasserIn  |4 aut 
700 1 |a Fehm, Tanja  |e VerfasserIn  |4 aut 
700 1 |a Capper, David  |d 1979-  |e VerfasserIn  |0 (DE-588)133950751  |0 (DE-627)558829902  |0 (DE-576)300212402  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Bonzheim, Irina  |e VerfasserIn  |4 aut 
700 1 |a Staebler, Annette  |e VerfasserIn  |4 aut 
700 1 |a Fend, Falko  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Human pathology  |d New York, NY [u.a.] : Elsevier, 1970  |g 44(2013), 3, Seite 329-335  |h Online-Ressource  |w (DE-627)326644784  |w (DE-600)2041481-X  |w (DE-576)094477272  |x 1532-8392  |7 nnas  |a Detection of the BRAF V600E mutation in serous ovarian tumors a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR 
773 1 8 |g volume:44  |g year:2013  |g number:3  |g pages:329-335  |g extent:7  |a Detection of the BRAF V600E mutation in serous ovarian tumors a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR 
856 4 0 |u https://doi.org/10.1016/j.humpath.2012.07.010  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0046817712002663  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201201 
993 |a Article 
994 |a 2013 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 133950751  |a Capper, David  |m 133950751:Capper, David  |d 910000  |d 912000  |e 910000PC133950751  |e 912000PC133950751  |k 0/910000/  |k 1/910000/912000/  |p 5 
999 |a KXP-PPN1741568218  |e 3815443571 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Hans","role":"aut","family":"Bösmüller","display":"Bösmüller, Hans"},{"given":"Anna","display":"Fischer, Anna","family":"Fischer","role":"aut"},{"role":"aut","family":"Pham","display":"Pham, Deborah L.","given":"Deborah L."},{"given":"Tanja","display":"Fehm, Tanja","role":"aut","family":"Fehm"},{"given":"David","display":"Capper, David","role":"aut","family":"Capper"},{"given":"Andreas von","display":"Deimling, Andreas von","family":"Deimling","role":"aut"},{"family":"Bonzheim","role":"aut","display":"Bonzheim, Irina","given":"Irina"},{"family":"Staebler","role":"aut","display":"Staebler, Annette","given":"Annette"},{"given":"Falko","role":"aut","family":"Fend","display":"Fend, Falko"}],"language":["eng"],"note":["Available online 22 October 2012","Gesehen am 01.12.2020"],"origin":[{"dateIssuedDisp":"2013","dateIssuedKey":"2013"}],"name":{"displayForm":["Hans Bösmüller, Anna Fischer, Deborah L. Pham, Tanja Fehm, David Capper, Andreas von Deimling, Irina Bonzheim, Annette Staebler, Falko Fend"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1741568218"],"doi":["10.1016/j.humpath.2012.07.010"]},"recId":"1741568218","title":[{"title":"Detection of the BRAF V600E mutation in serous ovarian tumors","subtitle":"a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR","title_sort":"Detection of the BRAF V600E mutation in serous ovarian tumors"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"part":{"issue":"3","year":"2013","pages":"329-335","extent":"7","volume":"44","text":"44(2013), 3, Seite 329-335"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Human pathology","title_sort":"Human pathology"}],"id":{"issn":["1532-8392"],"zdb":["2041481-X"],"eki":["326644784"]},"recId":"326644784","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Detection of the BRAF V600E mutation in serous ovarian tumors a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCRHuman pathology","origin":[{"publisher":"Elsevier","dateIssuedDisp":"1970-","dateIssuedKey":"1970","publisherPlace":"New York, NY [u.a.]"}],"pubHistory":["1.1970 -"],"note":["Gesehen am 21.07.25"],"language":["eng"]}]} 
SRT |a BOESMUELLEDETECTIONO2013